Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (121-130 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|September 24, 2016
Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application scheduleMichael Dobosz, Ute Haupt, Werner Scheuer
Mabs|July 6, 2017
Safety of biologics therapy: Monoclonal antibodies, cytokines, fusion proteins, hormones, enzymes, coagulation proteins, vaccines, botulinum toxinsStephen Mahler
Mabs|January 23, 2010
Cold denaturation of monoclonal antibodiesKristi L Lazar, Thomas W Patapoff, Vikas K Sharma
Mabs|July 12, 2018
Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cellsAlessandro Satta, Delia Mezzanzanica, Francesco Caroli, et al.
Mabs|March 10, 2015
Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasiaNicolas Azzopardi, Sophie Dupuis-Girod, David Ternant, et al.
Mabs|August 4, 2020
Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumabSandor Schokker, Fabrizia Fusetti, Francesco Bonardi, et al.
Mabs|April 9, 2023
Determination of ultra-trace metal-protein interactions in co-formulated monoclonal antibody drug product by SEC-ICP-MSLaurence Whitty-Léveillé, Zachary L VanAernum, Jorge Alexander Pavon, et al.
Mabs|July 8, 2020
Investigation of monoclonal antibody dimers in a final formulated drug by separation techniques coupled to native mass spectrometryG Rouby, N T Tran, Y Leblanc, et al.
Mabs|July 10, 2020
An evaluation of instrument types for mass spectrometry-based multi-attribute analysis of biotherapeuticsZhongqi Zhang, Pik K Chan, Jason Richardson, et al.
Mabs|March 12, 2015
Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemiaJenny Fitting, Tobias Blume, Andre Ten Haaf, et al.
Pageof 184

Showing results (121-130 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|September 24, 2016
Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application scheduleMichael Dobosz, Ute Haupt, Werner Scheuer
Mabs|July 6, 2017
Safety of biologics therapy: Monoclonal antibodies, cytokines, fusion proteins, hormones, enzymes, coagulation proteins, vaccines, botulinum toxinsStephen Mahler
Mabs|January 23, 2010
Cold denaturation of monoclonal antibodiesKristi L Lazar, Thomas W Patapoff, Vikas K Sharma
Mabs|July 12, 2018
Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cellsAlessandro Satta, Delia Mezzanzanica, Francesco Caroli, et al.
Mabs|March 10, 2015
Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasiaNicolas Azzopardi, Sophie Dupuis-Girod, David Ternant, et al.
Mabs|August 4, 2020
Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumabSandor Schokker, Fabrizia Fusetti, Francesco Bonardi, et al.
Mabs|April 9, 2023
Determination of ultra-trace metal-protein interactions in co-formulated monoclonal antibody drug product by SEC-ICP-MSLaurence Whitty-Léveillé, Zachary L VanAernum, Jorge Alexander Pavon, et al.
Mabs|July 8, 2020
Investigation of monoclonal antibody dimers in a final formulated drug by separation techniques coupled to native mass spectrometryG Rouby, N T Tran, Y Leblanc, et al.
Mabs|July 10, 2020
An evaluation of instrument types for mass spectrometry-based multi-attribute analysis of biotherapeuticsZhongqi Zhang, Pik K Chan, Jason Richardson, et al.
Mabs|March 12, 2015
Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemiaJenny Fitting, Tobias Blume, Andre Ten Haaf, et al.
Pageof 184